Market Cap 94.60B
Revenue (ttm) 372.81B
Net Income (ttm) 4.61B
EPS (ttm) N/A
PE Ratio 10.87
Forward PE 10.43
Profit Margin 1.24%
Debt to Equity Ratio 0.90
Volume 11,601,685
Avg Vol 8,293,764
Day's Range N/A - N/A
Shares Out 1.27B
Stochastic %K 46%
Beta 0.48
Analysts Strong Sell
Price Target $94.48

Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management serv...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
Armaster23
Armaster23 Feb. 4 at 8:59 PM
$CVS such a reactionary pos
0 · Reply
JazzPaw
JazzPaw Feb. 4 at 8:59 PM
$CVS I need some more bad news. This stock hasn’t dropped enough.
0 · Reply
RphTrader
RphTrader Feb. 4 at 8:44 PM
Arkansas has just destroyed $CVS business model.
0 · Reply
pilot12
pilot12 Feb. 4 at 8:28 PM
$CVS cvs negotiating possible settlement over insulin lawsuit with ftc
0 · Reply
GainsForMoon
GainsForMoon Feb. 4 at 8:21 PM
$CVS what changed in the last hour?
1 · Reply
Goodfellasfinancial
Goodfellasfinancial Feb. 4 at 7:56 PM
$CVS sold off my calls for a quick few bucks
0 · Reply
Mobgang77
Mobgang77 Feb. 4 at 3:58 PM
$CVS $79 today thoughts?
0 · Reply
ZacksResearch
ZacksResearch Feb. 4 at 1:58 PM
$CVS Q4 earnings preview: Can CVS maintain its winning streak? 🤔 📊 Revenue expected to rise 5.5% YoY to $103.1B, but EPS could fall 16.8% to 99 cents. 📈 Pharmacy segment poised for growth, while Health Care Benefits faces Medicaid pressures. ✅ Zacks Rank #3 + Earnings ESP of +0.38% = potential for a beat. Full analysis here 👉 https://www.zacks.com/stock/news/2828674/will-pharmacy-and-consumer-wellness-segment-lead-cvs-q4-earnings?cid=sm-stocktwits-2-2828674-body-31849&ADID=SYND_STOCKTWITS_TWEET_2_2828674_BODY_31849
0 · Reply
Cashflow62
Cashflow62 Feb. 4 at 1:46 PM
$CVS Looking for $77.50 today. Could be a little back and fill still think we hit that mark later.
1 · Reply
ZacksResearch
ZacksResearch Feb. 4 at 12:58 PM
Can $CVS’ Pharmacy and Consumer Wellness segment carry Q4 earnings? 👀💊 The focus is squarely on whether the Pharmacy and Consumer Wellness segment will lead CVS’ Q4 earnings performance — a key swing factor investors are watching closely this quarter. Want to see what’s driving the expectations? 👉 https://www.zacks.com/stock/news/2828674/will-pharmacy-and-consumer-wellness-segment-lead-cvs-q4-earnings?cid=sm-stocktwits-2-2828674-teaser-31837&ADID=SYND_STOCKTWITS_TWEET_2_2828674_TEASER_31837
0 · Reply
Latest News on CVS
CVS Health: Exploit The Sector Panic Ahead Of Earnings

Feb 3, 2026, 11:55 AM EST - 1 day ago

CVS Health: Exploit The Sector Panic Ahead Of Earnings


Stock Of The Day: Where Is The Bottom For CVS?

Jan 28, 2026, 12:24 PM EST - 7 days ago

Stock Of The Day: Where Is The Bottom For CVS?


Is CVS Stock The Best Of The Worst?

Jan 28, 2026, 8:35 AM EST - 7 days ago

Is CVS Stock The Best Of The Worst?


UNH Stock vs. CVS

Jan 15, 2026, 1:25 PM EST - 20 days ago

UNH Stock vs. CVS

UNH


Dividend Income: Lanny's November 2025 Summary

Jan 12, 2026, 5:12 AM EST - 23 days ago

Dividend Income: Lanny's November 2025 Summary

ABBV AFL CAT COF CZNC EMR ETN


CVS Health declares quarterly dividend

Jan 6, 2026, 8:59 AM EST - 4 weeks ago

CVS Health declares quarterly dividend


Final Trade: ETH, GM, CVS, NFLX

Dec 16, 2025, 6:21 PM EST - 7 weeks ago

Final Trade: ETH, GM, CVS, NFLX

GM NFLX ETH


Cramer's Stop Trading: CVS Health

Dec 10, 2025, 10:36 AM EST - 2 months ago

Cramer's Stop Trading: CVS Health


Buy Or Fear CVS Stock At $78?

Dec 10, 2025, 9:00 AM EST - 2 months ago

Buy Or Fear CVS Stock At $78?


Cramer's Mad Dash --- CVS Health

Dec 9, 2025, 9:48 AM EST - 2 months ago

Cramer's Mad Dash --- CVS Health


CVS forecasts 2026 profit above estimates on strong performance

Dec 9, 2025, 6:31 AM EST - 2 months ago

CVS forecasts 2026 profit above estimates on strong performance


CVS to pay $37.8 million to settle claims over insulin pens

Dec 2, 2025, 10:14 AM EST - 2 months ago

CVS to pay $37.8 million to settle claims over insulin pens


Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS

Dec 1, 2025, 8:00 AM EST - 2 months ago

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS


These outperforming stocks are still cheap heading into 2026

Nov 27, 2025, 2:15 PM EST - 2 months ago

These outperforming stocks are still cheap heading into 2026

MU NEM


Armaster23
Armaster23 Feb. 4 at 8:59 PM
$CVS such a reactionary pos
0 · Reply
JazzPaw
JazzPaw Feb. 4 at 8:59 PM
$CVS I need some more bad news. This stock hasn’t dropped enough.
0 · Reply
RphTrader
RphTrader Feb. 4 at 8:44 PM
Arkansas has just destroyed $CVS business model.
0 · Reply
pilot12
pilot12 Feb. 4 at 8:28 PM
$CVS cvs negotiating possible settlement over insulin lawsuit with ftc
0 · Reply
GainsForMoon
GainsForMoon Feb. 4 at 8:21 PM
$CVS what changed in the last hour?
1 · Reply
Goodfellasfinancial
Goodfellasfinancial Feb. 4 at 7:56 PM
$CVS sold off my calls for a quick few bucks
0 · Reply
Mobgang77
Mobgang77 Feb. 4 at 3:58 PM
$CVS $79 today thoughts?
0 · Reply
ZacksResearch
ZacksResearch Feb. 4 at 1:58 PM
$CVS Q4 earnings preview: Can CVS maintain its winning streak? 🤔 📊 Revenue expected to rise 5.5% YoY to $103.1B, but EPS could fall 16.8% to 99 cents. 📈 Pharmacy segment poised for growth, while Health Care Benefits faces Medicaid pressures. ✅ Zacks Rank #3 + Earnings ESP of +0.38% = potential for a beat. Full analysis here 👉 https://www.zacks.com/stock/news/2828674/will-pharmacy-and-consumer-wellness-segment-lead-cvs-q4-earnings?cid=sm-stocktwits-2-2828674-body-31849&ADID=SYND_STOCKTWITS_TWEET_2_2828674_BODY_31849
0 · Reply
Cashflow62
Cashflow62 Feb. 4 at 1:46 PM
$CVS Looking for $77.50 today. Could be a little back and fill still think we hit that mark later.
1 · Reply
ZacksResearch
ZacksResearch Feb. 4 at 12:58 PM
Can $CVS’ Pharmacy and Consumer Wellness segment carry Q4 earnings? 👀💊 The focus is squarely on whether the Pharmacy and Consumer Wellness segment will lead CVS’ Q4 earnings performance — a key swing factor investors are watching closely this quarter. Want to see what’s driving the expectations? 👉 https://www.zacks.com/stock/news/2828674/will-pharmacy-and-consumer-wellness-segment-lead-cvs-q4-earnings?cid=sm-stocktwits-2-2828674-teaser-31837&ADID=SYND_STOCKTWITS_TWEET_2_2828674_TEASER_31837
0 · Reply
ObsidianAdvisors
ObsidianAdvisors Feb. 4 at 11:27 AM
$CVS is an integrated healthcare services company navigating the Signify integration and rising medical costs in its insurance arm.
0 · Reply
WallstreetTopExp
WallstreetTopExp Feb. 3 at 10:54 PM
02/04/2026 watchlist! ❤️‍🔥 Inside Bar: (D) $CVS 🩺 Calls above $77.30 📈 Puts below $70.69 📉 $MU 💾 Calls above $455.50 📈 Puts below $407.13 📉 Gap Fill: (D) $KR 🥣 Calls above $65.18 📈 All-Time High Breakout: $LOW 🪵 Calls above $281.36 📈 Like This Post As A Sign Of Appreciation! 💚
0 · Reply
Hugo_Egon
Hugo_Egon Feb. 3 at 8:59 PM
$TDOC - will be bought by $WMT $CVS or $AMZN ?? What do you think? Let’s vote 😃😉
1 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:18 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CNC $CVS $UNH $WBA
0 · Reply
vagellie007
vagellie007 Feb. 3 at 3:06 PM
$CVS is this gonna pull a microsoft after earnings?
1 · Reply
AnalystOnTheEdge
AnalystOnTheEdge Feb. 2 at 6:42 PM
$HUM $UNH $CVS Medicare Advantage (MA) rates come in two’s increments: INITIAL (Advance Notice) issued in JAN FINAL (Rate Announcement) issued in APR Note - INITIAL is not very accurate as a predictor. CMS almost always raises the FINAL, typically 1-3% ⬆️
1 · Reply
Jas45z
Jas45z Feb. 2 at 5:08 PM
$CVS To confirm a new bullish trend, the stock needs to clear the following hurdles: Primary Resistance (Short-Term): $75.00 I view $75.00 as a psychological and structural pivot. A clean break above this level would signal a recovery from the recent January dip. Secondary Resistance (Mid-Term): $80.00 – $81.50 This range acted as a ceiling throughout early January. A breakout above $81.50 would likely confirm a "bullish breakout" and potentially pave the way for a run toward the consensus analyst target of $95.00. Long-Term Targets: If momentum sustains, major resistance sits at $85.95 and $91.03.
2 · Reply
Cashflow62
Cashflow62 Feb. 2 at 12:02 PM
$CVS $77-$78 by Friday.
1 · Reply
ggoggo
ggoggo Feb. 1 at 8:45 PM
$CVS gonna test 60 ???
2 · Reply
Jas45z
Jas45z Feb. 1 at 4:14 PM
$CVS I took a flyer at 71.33- here’s why. As of early 2026, CVS is trading at a significant discount to the broader healthcare sector. The 2026 Reset: Management has guided for 2026 EPS of $7.00 – $7.20, representing a recovery from the "restructuring years" of 2024-2025. The Valuation Gap: CVS often trades at a forward P/E of ~11x, while UNH typically commands 18x-20x. Bulls argue that as the "David Joyner era" proves its operational discipline, that gap will close, leading to massive multiple expansion. Dividend Yield: With a yield of ~3.6%, you are being paid to wait for the turnaround—a yield significantly higher than most of its mega-cap healthcare peers.
0 · Reply
beestMod516
beestMod516 Jan. 31 at 4:59 PM
Another proof Wall Street doesn’t care about balance sheet or fundamentals: $HIMS $NVO $CVS
1 · Reply
Sunny3999
Sunny3999 Jan. 30 at 1:07 PM
$PMN News $175 million private placement https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $CNC $CVS $UNH $WBA
0 · Reply